Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.3522 | 1 | 0.5 |
Brugia malayi | dihydrofolate reductase family protein | 0.2491 | 0.6972 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.3522 | 1 | 1 |
Echinococcus multilocularis | dihydrofolate reductase | 0.2491 | 0.6972 | 1 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.2491 | 0.6972 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.2491 | 0.6972 | 1 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.3522 | 1 | 0.5 |
Echinococcus multilocularis | thymidylate synthase | 0.2018 | 0.5582 | 0.8007 |
Trichomonas vaginalis | conserved hypothetical protein | 0.096 | 0.2475 | 0.5 |
Echinococcus granulosus | geminin | 0.0164 | 0.0138 | 0.0198 |
Chlamydia trachomatis | dihydrofolate reductase | 0.2491 | 0.6972 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.2018 | 0.5582 | 0.8007 |
Echinococcus multilocularis | geminin | 0.0164 | 0.0138 | 0.0198 |
Brugia malayi | thymidylate synthase | 0.2018 | 0.5582 | 0.8007 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.2491 | 0.6972 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.0138 | 0.0198 |
Brugia malayi | hypothetical protein | 0.096 | 0.2475 | 0.355 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 0.0138 | 0.0198 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.3522 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.2018 | 0.5582 | 0.691 |
Loa Loa (eye worm) | thymidylate synthase | 0.2018 | 0.5582 | 0.8007 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.3522 | 1 | 0.5 |
Schistosoma mansoni | dihydrofolate reductase | 0.2491 | 0.6972 | 1 |
Echinococcus granulosus | dihydrofolate reductase | 0.2491 | 0.6972 | 1 |
Onchocerca volvulus | 0.2018 | 0.5582 | 1 | |
Brugia malayi | Dihydrofolate reductase | 0.2491 | 0.6972 | 1 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.2491 | 0.6972 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.2018 | 0.5582 | 0.8007 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 2000 nM | Evaluated for concentration which when added to cultures of L1210 leukemia cells for a period of 70 h reduces cell numbers of 50% of control cultures | ChEMBL. | 3572974 |
IC50 (functional) | > 2000 nM | Evaluated for concentration which when added to cultures of L1210 leukemia cells for a period of 70 h reduces cell numbers of 50% of control cultures | ChEMBL. | 3572974 |
ID50 (functional) | > 2000 nM | Concentration required for 50% reduction of counted L1210 cells upon exposure for a period of 70h | ChEMBL. | 6492078 |
ID50 (functional) | > 2000 nM | Concentration required for 50% reduction of counted L1210 cells upon exposure for a period of 70h | ChEMBL. | 6492078 |
ID50 (functional) | > 5000 nM | Concentration of the compound required for 50% reduction of counted HCT-8 cells upon exposure for a period of 70h | ChEMBL. | 6492078 |
ID50 (functional) | > 5000 nM | Concentration of the compound required for 50% reduction of counted HCT-8 cells upon exposure for a period of 70h | ChEMBL. | 6492078 |
ILS (functional) | NA 0 | Percentage increase in life span treated animals over those of controls injected with P388 leukemia cells; NA means no activity (ILS<20%) at all dose levels | ChEMBL. | 3572974 |
Log K (ADMET) | = 7.18 | Logarithmic association constant determined by ethidium displacement from DNA co-polymers (adenine & thymine) | ChEMBL. | 6492078 |
Log K (binding) | = 7.18 | Logarithm of association constant for binding to DNA by ethidium displacement | ChEMBL. | 3572974 |
Log K (ADMET) | = 7.66 | Logarithmic association constant determined by ethidium displacement from DNA co-polymers (G + C) | ChEMBL. | 6492078 |
Log K (binding) | = 7.66 | Logarithm of association constant for binding to DNA by ethidium displacement | ChEMBL. | 3572974 |
Log K delta (binding) | = 0.48 | Difference between log K of (AT) and log K of (GC) DNA binding | ChEMBL. | 3572974 |
OD (functional) | = 250 mg kg-1 | Compound administered intraperitoneally was evaluated for optimal dose (OD) given per day after inoculation of 10e 6 P388 leukemia cells for highest nontoxic dose | ChEMBL. | 3572974 |
OD (functional) | = 250 mg kg-1 | Compound administered intraperitoneally was evaluated for optimal dose (OD) given per day after inoculation of 10e 6 P388 leukemia cells for highest nontoxic dose | ChEMBL. | 3572974 |
Ratio (functional) | 0 | Ratio of DNA dissociation constant from calf thymus; ND means no data | ChEMBL. | 3572974 |
Ratio (functional) | = 3.6 | Ratio T3/T2 of DNA dissociation constant from calf thymus | ChEMBL. | 3572974 |
Ratio (functional) | = 4.5 | Ratio T2/T1 of DNA dissociation constant from calf thymus | ChEMBL. | 3572974 |
Rm | = -1.06 | Lipophilicity (Rm) (RP-TLC) | ChEMBL. | 6492078 |
Time constant T1 (functional) | = 6 ms | DNA dissociation constant from calf thymus | ChEMBL. | 3572974 |
Time constant T2 (functional) | = 27 ms | DNA dissociation constant was determined from calf thymus | ChEMBL. | 3572974 |
Time constant T3 (functional) | = 98 ms | DNA dissociation constant from calf thymus | ChEMBL. | 3572974 |
Time constant T4 (functional) | 0 | DNA dissociation constant from calf thymus; ND means no data | ChEMBL. | 3572974 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 3572974 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.